Scientists identify potential new ‘soldier’ for cancer immunotherapy
The new cells, which the scientists have dubbed killer innate-like T cells, differ in several notable ways from the conventional target of many immunotherapies.
Materials provided by Memorial Sloan Kettering Cancer Center. Note: Content may be edited for style and length.
Source link aaaaa